StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the stock. A number of other equities research analysts have also issued reports on the company. Jefferies Financial Group lowered Reata Pharmaceuticals from a buy rating to […]
StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report report published on Saturday. The brokerage issued a sell rating on the stock. Several other research analysts have also commented on RETA. LADENBURG THALM/SH SH lowered shares of Reata Pharmaceuticals from a buy rating to a neutral rating and […]
Short Interest in Reata Pharmaceuticals, Inc (NASDAQ:RETA) Decreases By 38 1% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Altium Capital Management LP bought a new stake in Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 35,000 shares of the company’s stock, valued at approximately $3,182,000. Reata Pharmaceuticals makes up 1.8% of Altium Capital […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $170.83 and last traded at $170.83, with a volume of 25211 shares traded. The stock had previously closed at $170.32. Analysts Set New Price Targets A number of research firms have weighed in […]